获得性纯巨核细胞再生障碍：1例接受霉酚酸酯治疗的病例报告。
Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.
作者信息
Bulchandani Deepti, Nachnani Jagdish, Belt Robert, Hinton Stuart
机构信息
Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.
出版信息
Am J Hematol. 2007 Jul;82(7):650-1. doi: 10.1002/ajh.20895.
Acquired pure megakaryocytic aplasia (APMA) is a rare disorder in the field of hematological diseases. We report the case of a patient with APMA treated with mycophenolate mofetil and review the literature associated with this. Until today, very few cases of APMA have been reported and the disease etiology still seems to be unclear. There have been no reported cases of treatment of APMA treated with mycophenolate mofetil.
获得性纯巨核细胞再生障碍性贫血（APMA）是血液疾病领域中的一种罕见病症。我们报告了1例接受霉酚酸酯治疗的APMA患者，并回顾了与之相关的文献。直至今日，APMA的报道病例极少，且疾病病因似乎仍不明确。尚无使用霉酚酸酯治疗APMA的报道病例。
Zotero 插件